VDR and metabolic dysfunction-associated steatotic liver disease: Simultaneously, the 8-methoxypsoralen, a vitamin D receptor ligand with a promising antisteatosis action, can relieve the symptoms of NAFLD by binding to vitamin D receptor [27].